About Clusterin-like protein 1
Clusterin-like protein 1 (CLUL1) is a protein
from Homo sapiens identified by UniProt accession
Q15846, 466 residues long.
MolForge cross-references it against 0 known binders and
20 disease associations.
Target properties
| Protein name | Clusterin-like protein 1 |
| UniProt accession | Q15846 |
| Gene | CLUL1 |
| Organism | Homo sapiens |
| Length | 466 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (20)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.37
- mean corpuscular volume · score 0.21
- Testicular Germ Cell Tumor · score 0.19
- serum gamma-glutamyl transferase measurement · score 0.04
- benign neoplasm · score 0.04
- systolic blood pressure · score 0.03
- protein measurement · score 0.02
- urate measurement · score 0.02
- bone density · score 0.02
- drug use measurement · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q15846-F1 | alphafold | PREDICTED | 64.65 | — |
Amino-acid sequence (466 residues)
MKPPLLVFIV CLLWLKDSHC APTWKDKTAI SENLKSFSEV GEIDADEEVK KALTGIKQMK IMMERKEKEH TNLMSTLKKC REEKQEALKL LNEVQEHLEE EERLCRESLA DSWGECRSCL ENNCMRIYTT CQPSWSSVKN KIERFFRKIY QFLFPFHEDN EKDLPISEKL IEEDAQLTQM EDVFSQLTVD VNSLFNRSFN VFRQMQQEFD QTFQSHFISD TDLTEPYFFP AFSKEPMTKA DLEQCWDIPN FFQLFCNFSV SIYESVSETI TKMLKAIEDL PKQDKAPDHG GLISKMLPGQ DRGLCGELDQ NLSRCFKFHE KCQKCQAHLS EDCPDVPALH TELDEAIRLV NVSNQQYGQI LQMTRKHLED TAYLVEKMRG QFGWVSELAN QAPETEIIFN SIQVVPRIHE GNISKQDETM MTDLSILPSS NFTLKIPLEE SAESSNFIGY VVAKALQHFK EHFKTW
Explore Clusterin-like protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets